Dr Reddy's Lab completed a GMP inspection with zero observation in Bollaram, Hyderabad plant.
The United States Food & Drug Administration (USFDA) completed a GMP inspection at our API manufacturing facility in Bollaram, Hyderabad (CTO-3). The inspection was conducted from June 12, 2023 to June 16, 2023. The inspection closed with zero observations.
Additionally, further to our intimation dated May 12, 2023, on the inspection conducted by the USFDA at our formulations manufacturing facility in Srikakulam (FTO SEZ PU2), in which the Company has received the Establishment Inspection Report (EIR).
The Agency has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is "closed" under 21 CFR 20.64(d)(3).
